ArticleAmerican journal of cancer research2023

Safety of dendritic cell and cytokine-induced killer (DC-CIK) cell-based immunotherapy in patients with solid tumor: a retrospective study in China.

Shuo Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.